Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05254171
Title Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Pancreatic Cancer (ASPIRE)
Acronym ASPIRE
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Panbela Therapeutics, Inc
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | ITA | GBR | FRA | ESP | DEU | BEL | AUT | AUS


No variant requirements are available.